Identification of a Novel Redox-Sensitive Gene, Id3, Which Mediates Angiotensin II–Induced Cell Growth
- 21 May 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (20) , 2423-2428
- https://doi.org/10.1161/01.cir.0000016047.19488.91
Abstract
Background— Reactive oxygen species, such as superoxide (O2−), are involved in the abnormal growth of various cell types. Angiotensin II (Ang II) is one of the most potent inducers of oxidative stress in the vasculature. The molecular events involved in Ang II–induced proliferation of vascular smooth muscle cells (VSMCs) are only partially understood. Methods and Results— Ang II as well as xanthine/xanthine oxidase (X/XO) led to enhanced DNA synthesis and proliferation of VSMCs. The effect of Ang II was abolished by diphenylene iodonium. Consequently, VSMCs were incubated with X/XO, and modulation of gene expression was monitored by differential display, leading to the identification of a novel redox-sensitive gene, the dominant-negative helix-loop-helix protein Id3, which was upregulated within 30 minutes by X/XO and Ang II. Superoxide dismutase but not catalase inhibited this effect. Overexpression of antisense Id3 via transfection in VSMCs completely abolished Ang II– and X/XO-induced cell proliferatio...Keywords
This publication has 18 references indexed in Scilit:
- Cell signaling by reactive nitrogen and oxygen species in atherosclerosisFree Radical Biology & Medicine, 2000
- Cell Cycle Proteins and AtherosclerosisHerz, 2000
- Vascular oxidant stress: Molecular mechanisms and pathophysiological implicationsJournal of Physiology and Biochemistry, 2000
- Oxyradicals and DNA damageCarcinogenesis: Integrative Cancer Research, 2000
- Differential Regulation of P27Kip1 Expression by Mitogenic and Hypertrophic FactorsThe Journal of cell biology, 2000
- Review article: chronic inflammation and reactive oxygen and nitrogen metabolism – implications in DNA damage and mutagenesisAlimentary Pharmacology & Therapeutics, 2000
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- A novel role for the cyclin-dependent kinase inhibitor p27Kip1 in angiotensin II–stimulated vascular smooth muscle cell hypertrophyJournal of Clinical Investigation, 1999
- Regulation of the Expression of Cyclin-Dependent Kinase Inhibitor p21 by E2A and Id ProteinsMolecular and Cellular Biology, 1997
- Monitoring of Cardiovascular Disease and Risk Factor Trends: Experiences from the WHO/MONICA ProjectAnnals of Medicine, 1994